Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Valiant Laboratories Ltd

Pharmaceuticals & Biotechnology | Small Cap

Valiant Laboratories Ltd Health Insights
Health Score : 4.37Health Score : 4.37

Valiant Laboratories, operating within the Healthcare Services sector, shows a mixed financial performance. The company demonstrates strong solvency, driven by a solid equity ratio and no debt. However, liquidity is poor, indicating potential difficulties in meeting short-term obligations. Efficiency is also a concern, with low turnover ratios except for days sales in inventory and receivable days, suggesting challenges in asset utilization. Growth metrics reveal declining revenue and profit, though asset growth is positive. Profitability is varied, with some positive returns but negative margins. Overall, the company's financial health presents a mixed picture, with strengths in solvency offset by weaknesses in liquidity, efficiency, and recent growth trends. It's crucial to monitor these areas to ensure sustainable performance. There is a need to address the issues with liquidity and efficiency.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Valiant Laboratories Ltd Health Insights
Health Score : 4.37Health Score : 4.37

Valiant Laboratories, operating within the Healthcare Services sector, shows a mixed financial performance. The company demonstrates strong solvency, driven by a solid equity ratio and no debt. However, liquidity is poor, indicating potential difficulties in meeting short-term obligations. Efficiency is also a concern, with low turnover ratios except for days sales in inventory and receivable days, suggesting challenges in asset utilization. Growth metrics reveal declining revenue and profit, though asset growth is positive. Profitability is varied, with some positive returns but negative margins. Overall, the company's financial health presents a mixed picture, with strengths in solvency offset by weaknesses in liquidity, efficiency, and recent growth trends. It's crucial to monitor these areas to ensure sustainable performance. There is a need to address the issues with liquidity and efficiency.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

64.80

Highly Undervalued

Industry Median

23.93

Highly Undervalued
Highly Undervalued

Small Cap Median

23.93

Highly Undervalued

P/E RATIO

-199.15

P/B RATIO

1.40

Undervalued

Industry Median

2.53

Undervalued
Undervalued

Small Cap Median

2.53

Undervalued

P/S RATIO

3.33

Neutral

Industry Median

1.35

Neutral
Overvalued

Small Cap Median

1.35

Overvalued

Others

Neutral

PEG RATIO

0.00

Neutral
Neutral

EV/EBITDA RATIO

0.00

Neutral

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹81.65 as on Apr 29, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 2.80

The company's growth ratios indicate a period of decline, with drops in revenue, operating profit, and earnings per share. However, there is positive asset growth. This suggests potential investments in future capabilities. While the asset growth is a positive sign, addressing the negative trends in revenue and profitability is critical for sustainable growth.

PoorRevenue Growth RatePoor
PoorOperating Profit Growth RatePoor
PoorEarnings Per Share (EPS) GrowthPoor
ExcellentAsset Growth RateExcellent
PoorNet Income Growth RatePoor
Growth RatiosMar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate-45.51-26.9278.2
Operating Profit Growth Rate-122.86-37.5-220
Earnings Per Share (EPS) Growth-99.16-783.3346.34
Asset Growth Rate61.0316.9115.71
Net Income Growth Rate-10050
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 2.00

The company's financial ratios show a mixed performance. While capital expenditures are well-managed, adjusted EPS, cash EPS, book value per share, and dividend per share are concerning. Enhancing earnings and book value is essential for boosting investor confidence. In the healthcare sector, balancing financial performance with investments in patient care is critical.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
ExcellentCapital Expenditures (CapEx)Excellent
Financial RatiosMar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)8.79-0.74-0.73-0.56
Cash Earnings Per Share (Cash EPS)9.390.4700.56
Book Value Per Share30.6154.8854.4257.59
Dividend Per Share (DPS)0000
Capital Expenditures (CapEx)384611434
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 3.00

The company's profitability ratios present a mixed picture. The return on capital employed and the return on equity are strong, while the gross profit margin, return on assets, operating margin, and net margin need attention. A balanced approach to improving margins and asset utilization is essential for sustainable profitability. The healthcare industry requires continuous investment in technology and infrastructure.

PoorGross Profit MarginPoor
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
PoorReturn on Assets (ROA)Poor
PoorOperating MarginPoor
ExcellentNet MarginExcellent
Profitability RatiosMar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin9.88-5.49-5.260
Return on Capital Employed (ROCE)23.57-2-11
Return on Equity (ROE)28.710-0.85-0.96
Return on Assets (ROA)16.43-2.33-1.251.29
Operating Margin10.48-4.4-3.762.53
Net Margin8.680-1.5-1.27
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 1.00

The company's efficiency ratios present a mixed picture. There are low turnover ratios, except for days sales in inventory and receivable days. This suggests inefficient asset utilization and working capital management. Improving these ratios could lead to substantial gains in operational effectiveness and profitability. The healthcare sector requires efficient asset management to optimize resource allocation and patient care services.

PoorFixed Asset Turnover RatioPoor
PoorInventory Turnover RatioPoor
PoorReceivables Turnover RatioPoor
ExcellentDays Sales in Inventory RatioExcellent
ExcellentReceivable DaysExcellent
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio6.963.642.771.04
Inventory Turnover Ratio23.1516.7209.67
Receivables Turnover Ratio3.762.72.252.86
Days Sales in Inventory Ratio15.7721.8618.2537.75
Receivable Days97135.19162.22127.62
Capital Turnover Ratio2.070.580.390.7
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 1.00

The company's coverage ratios are very low, indicating difficulties in covering interest and dividend obligations. This suggests a need for improved profitability and cash flow management. While the healthcare industry can have varying coverage needs, maintaining adequate coverage is essential for financial stability.

PoorInterest Coverage RatioPoor
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage RatioN/AN/AN/A1.5
Equity Dividend Coverage Ratio
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 5.00

The company exhibits strong solvency, primarily due to a high equity ratio and no debt, indicating a solid financial foundation and low risk of financial distress. This position allows the company to have financial flexibility for future investments and growth opportunities. However, relying solely on equity may limit access to capital for expansion or strategic initiatives.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.370.240.310.09
Debt to Equity Ratio0.590.320.450.1
Equity Ratio0.630.760.690.91
Debt To Asset Ratio0.280.220.260.06
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 2.00

The company's liquidity position is weak, suggesting potential difficulties in meeting its short-term obligations. The weighted average calculation highlights consistent challenges across current, quick, and cash ratios. This necessitates a careful review of working capital management to ensure timely payments and operational stability. While the healthcare industry can face fluctuating cash flows, maintaining sufficient liquidity is vital for smooth operations.

PoorCurrent RatioPoor
PoorQuick RatioPoor
PoorCash RatioPoor
PoorOperating Cash Flow RatioPoor
Liquidity RatiosMar 2023Mar 2024Mar 2025Mar 2026
Current Ratio2.56.983.181.63
Quick Ratio2.256.653.121.27
Cash Ratio0.023.491.230.06
Operating Cash Flow Ratio1.080.070.02-0.08
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 1 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Valiant Laboratories Ltd4.37-199.15Neutral6.001.02-3.00
Management Assessment Summary
OrangeBalanced Management

The management effectiveness of Valiant Laboratories presents a mixed picture. A significant concern is the substantial decline in sales and profitability over the past two years, reflected in negative operating profit margins. However, the consistent promoter holding suggests confidence in the company's long-term prospects. The increasing borrowings, coupled with declining sales, raise concerns about financial leverage and the efficiency of capital allocation. While there are areas of concern, stable promoter holding provides a degree of stability. Therefore, the overall management effectiveness is rated as mixed.

Category Metric Value Assessment
PROS Promoter Holding 74.94% Consistent promoter holding indicates confidence.
CONS Sales Growth -26.74% Declining sales growth indicates challenges.
Operating Profit Margin (OPM) -4% Negative OPM reflects operational inefficiency.
Borrowings ₹122 Cr. Increasing borrowings raise concerns about leverage.
PoorFinancial Performance & GrowthPoor
WeakCapital Efficiency & ReturnsWeak
AverageFinancial Health & PrudenceAverage
GoodShareholding & Ownership StructureGood
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

Valiant Laboratories faces a moderate level of risk due to its declining financial performance and increasing leverage. The negative operating profit margins and inconsistent profitability, coupled with a rise in borrowings, create financial strain. The decrease in FII holdings suggests a potential lack of confidence from institutional investors. Operational inefficiencies are indicated by an increasing cash conversion cycle and working capital days.

AverageOff-balance sheet exposure quantificationAverage
AverageContingent liability evaluationAverage
AverageAccounting quality red flagsAverage
AverageSegment performance volatilityAverage
AverageForeign exchange or interest rate exposureAverage
AverageRegulatory compliance cost trendsAverage
01.

Off-balance sheet exposure quantification

02.

Contingent liability evaluation

03.

Accounting quality red flags

04.

Segment performance volatility

05.

Foreign exchange or interest rate exposure

06.

Regulatory compliance cost trends

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe